Preclinical News and Research

RSS
Research illuminates why stimulating environment may protect against Alzheimer's disease

Research illuminates why stimulating environment may protect against Alzheimer's disease

Targeting ARF6 may be effectively prevent melanoma metastasis to lungs

Targeting ARF6 may be effectively prevent melanoma metastasis to lungs

Scientists discover key biochemical step underlying heart failure

Scientists discover key biochemical step underlying heart failure

Idera announces new data from IMO-3100 and IMO-8400 preclinical study on psoriasis

Idera announces new data from IMO-3100 and IMO-8400 preclinical study on psoriasis

PsiOxus completes enrollment in MT-102 Phase II trial on cancer cachexia

PsiOxus completes enrollment in MT-102 Phase II trial on cancer cachexia

Study finds how to shut down Bcl6 in diffuse large B-cell lymphoma

Study finds how to shut down Bcl6 in diffuse large B-cell lymphoma

Pivotal study of olesoxime in Spinal Muscular Atrophy receives positive interim review

Pivotal study of olesoxime in Spinal Muscular Atrophy receives positive interim review

EpiCept fourth quarter revenue decreases to $0.1 million

EpiCept fourth quarter revenue decreases to $0.1 million

Novel immunotherapy could potentially work like a vaccine against metastatic cancers

Novel immunotherapy could potentially work like a vaccine against metastatic cancers

MenB bacterium uses Adhesin Complex Protein to stick to human cells

MenB bacterium uses Adhesin Complex Protein to stick to human cells

Resolve Therapeutics, Takeda partner to develop compounds for treatment of lupus

Resolve Therapeutics, Takeda partner to develop compounds for treatment of lupus

CellAegis Devices to use autoRIC Device for Chronic Remote Ischemic Conditioning

CellAegis Devices to use autoRIC Device for Chronic Remote Ischemic Conditioning

Study opens possibility for creating animal models of memory disorders

Study opens possibility for creating animal models of memory disorders

Two discriminating biological markers found to predict a favorable response to treatment in triple-negative breast cancer

Two discriminating biological markers found to predict a favorable response to treatment in triple-negative breast cancer

4SC Discovery enters exclusive research and license agreement with LEO Pharma

4SC Discovery enters exclusive research and license agreement with LEO Pharma

Surefire Medical’s latest line of infusion system and specialty catheters receive CE Mark approval

Surefire Medical’s latest line of infusion system and specialty catheters receive CE Mark approval

Sius single-use tangential flow filtration skid from Novasep

Sius single-use tangential flow filtration skid from Novasep

Recombinant Newcastle disease virus kills all kinds of prostate cancer cells

Recombinant Newcastle disease virus kills all kinds of prostate cancer cells

Adynxx initiates AYX1 Phase 2 study to prevent post-surgical pain

Adynxx initiates AYX1 Phase 2 study to prevent post-surgical pain

Okairos to commence novel RSV vaccine Phase I clinical trial

Okairos to commence novel RSV vaccine Phase I clinical trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.